Increase of HMGB1 in Lungs After Acute Exacerbation of Pulmonary Fibrosis
Author Information
Author(s): Ebina Masahito, Taniguchi Hiroyuki, Miyasho Taku, Yamada Shingo, Shibata Naoko, Ohta Hiromitsu, Hisata Shu, Ohkouchi Shinya, Tamada Tsutomu, Nishimura Hidekazu, Ishizaka Akitoshi, Maruyama Ikuro, Okada Yoshinori, Takashi Kondo, Nukiwa Toshihiro
Primary Institution: Tohoku University Graduate School of Medicine
Hypothesis
What roles do inflammatory mediators play in the acute exacerbation of idiopathic pulmonary fibrosis?
Conclusion
HMGB1 and MCP-1 levels increase in the lungs of patients with idiopathic pulmonary fibrosis after acute exacerbation, suggesting their involvement in the disease's pathogenesis.
Supporting Evidence
- HMGB1 levels were low initially but increased after acute exacerbation.
- MCP-1 levels correlated positively with HMGB1 levels.
- Intense cytoplasmic staining for HMGB1 was observed in lung tissues of patients after acute exacerbation.
Takeaway
This study found that a protein called HMGB1 goes up in the lungs of people with a serious lung disease after they get worse, which might help explain why they feel worse.
Methodology
The study measured HMGB1 and inflammatory cytokines in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis after acute exacerbation.
Potential Biases
Potential bias may arise from the selection of patients and the observational nature of the study.
Limitations
The study was limited by the small sample size and the lack of control for potential confounding factors.
Participant Demographics
Patients included seven individuals with idiopathic pulmonary fibrosis who experienced acute exacerbation.
Statistical Information
P-Value
0.008
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website